Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Significance of Membrane Transport01:44

The Significance of Membrane Transport

The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Simple diameters, accurate stages:a practical approach to HD-ISS staging.

Journal of neurology·2026
Same author

Simple diameters, accurate stages:a practical approach to HD-ISS staging.

Journal of neurology·2025
Same author

Trajectories of Pontine Volume in Patients with Multiple System Atrophy.

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Combined cognitive assessment and automated MRI volumetry improves the diagnostic accuracy of detecting MCI due to Alzheimer's disease.

Progress in neuro-psychopharmacology & biological psychiatry·2024
Same author

A Blinded Evaluation of Brain Morphometry for Differential Diagnosis of Atypical Parkinsonism.

Movement disorders clinical practice·2024
Same author

Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging Study.

Movement disorders : official journal of the Movement Disorder Society·2023

Related Experiment Video

Updated: Jun 19, 2026

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
11:26

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake

Published on: September 21, 2017

Dopamine transporter SPECT: how to remove subjectivity?

Christoph Scherfler1, Michael Nocker

  • 1Department of Neurology, Innsbruck Medical University, Anichstrasse 35, Innsbruck, Austria. christoph.scherfler@i-med.ac.at

Movement Disorders : Official Journal of the Movement Disorder Society
|October 31, 2009
PubMed
Summary

Single photon emission computed tomography (SPECT) aids in diagnosing uncertain parkinsonian syndromes by assessing striatal dopamine transporter (DAT) status. Automated analysis techniques show promise for improving diagnostic accuracy in these challenging cases.

More Related Videos

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons
06:18

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons

Published on: April 3, 2014

Related Experiment Videos

Last Updated: Jun 19, 2026

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
11:26

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake

Published on: September 21, 2017

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons
06:18

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons

Published on: April 3, 2014

Area of Science:

  • Neurology
  • Nuclear Medicine
  • Medical Imaging

Background:

  • Clinical diagnosis of parkinsonian syndromes is accurate when cardinal features are evident.
  • Uncertain cases, including isolated tremors and atypical parkinsonism, pose diagnostic challenges.
  • Striatal dopamine transporter (DAT) Single Photon Emission Computed Tomography (SPECT) is explored to enhance diagnostic precision.

Purpose of the Study:

  • To review the utility of DAT-SPECT in diagnosing uncertain parkinsonian syndromes.
  • To evaluate various analytical approaches for DAT-SPECT imaging.
  • To assess the potential of automated image analysis in improving diagnostic accuracy.

Main Methods:

  • Review of existing literature on DAT-SPECT analysis techniques.
  • Comparison of visual assessment, semiquantitative analysis (region of interest), and automated image analysis.
  • Validation of automated techniques in clinical settings.

Main Results:

  • Visual and semiquantitative DAT-SPECT analyses are recommended for routine work-up.
  • Automated image-analysis techniques have been validated clinically.
  • These methods aim to improve diagnostic accuracy for parkinsonian features.

Conclusions:

  • DAT-SPECT, particularly with advanced analysis, can improve the diagnosis of challenging parkinsonian syndromes.
  • Automated image analysis offers a promising tool for objective and accurate assessment.
  • Further integration of these techniques is suggested for clinical practice.